Literature DB >> 11488575

Dosimetry of pulsed clinical proton beams by a small ionization chamber.

A Nohtomi1, T Sakae, Y Tsunashima, R Kohno.   

Abstract

Response of a micro volume (0.01 ml) ionization chamber has been studied with pulsed proton beams which are used for clinical purposes and has been compared with those of some JARP ionization chambers (0.6 ml). All chambers used had been calibrated by standard 60Co beams at the Electrotechnical Laboratory (ETL) and exposure calibration factors, Nx, were obtained on advance. Two methods are used to compensate the general recombination which occurs during pulsed beam irradiations: theoretical correction by a Boag's formulation and a modified two-voltage technique. An evaluation of absolute absorbed dose-to-water is performed on the basis of the protocol provided by ICRU report 59. The results imply that, to a first approximation, both chambers indicate the almost same result within 2% when unknown chamber-dependent parameters of the micro chamber are tentatively assumed to be identical to those of the JARP chamber for the calibration with 60Co beams. The about 1.5% discrepancy observed in the response of both chambers is not discussible due to presumably 1-2% uncertainty of the protocol of ICRU report 59 which does not include any chamber-dependent corrections for the perturbation effects in proton beams.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488575     DOI: 10.1118/1.1380435

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  5 in total

1.  Clinical characterization of a proton beam continuous uniform scanning system with dose layer stacking.

Authors:  J B Farr; A E Mascia; W C Hsi; C E Allgower; F Jesseph; A N Schreuder; M Wolanski; D F Nichiporov; V Anferov
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

2.  The major DNA repair pathway after both proton and carbon-ion radiation is NHEJ, but the HR pathway is more relevant in carbon ions.

Authors:  Ariungerel Gerelchuluun; Eri Manabe; Takaaki Ishikawa; Lue Sun; Kazuya Itoh; Takeji Sakae; Kenshi Suzuki; Ryoichi Hirayama; Aroumougame Asaithamby; David J Chen; Koji Tsuboi
Journal:  Radiat Res       Date:  2015-03-04       Impact factor: 2.841

3.  Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma.

Authors:  Kuniaki Fukuda; Toshiyuki Okumura; Masato Abei; Nobuyoshi Fukumitsu; Kazunori Ishige; Masashi Mizumoto; Naoyuki Hasegawa; Haruko Numajiri; Kayoko Ohnishi; Hitoshi Ishikawa; Koji Tsuboi; Hideyuki Sakurai; Ichinosuke Hyodo
Journal:  Cancer Sci       Date:  2017-03       Impact factor: 6.716

4.  Indicator for local recurrence of hepatocellular carcinoma after proton beam therapy: analysis of attenuation difference between the irradiated tumor and liver parenchyma on contrast enhancement CT.

Authors:  Hiroaki Takahashi; Yuta Sekino; Kensaku Mori; Toshiyuki Okumura; Katsuhiro Nasu; Kuniaki Fukuda; Sota Masuoka; Takashi Iizumi; Naoyuki Hasegawa; Hideyuki Sakurai; Manabu Minami
Journal:  Br J Radiol       Date:  2019-11-07       Impact factor: 3.039

5.  Histone Deacetylase Inhibitor Induced Radiation Sensitization Effects on Human Cancer Cells after Photon and Hadron Radiation Exposure.

Authors:  Ariungerel Gerelchuluun; Junko Maeda; Eri Manabe; Colleen A Brents; Takeji Sakae; Akira Fujimori; David J Chen; Koji Tsuboi; Takamitsu A Kato
Journal:  Int J Mol Sci       Date:  2018-02-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.